Stock Market Reviews

Read and share opinions on LRMR (Larimar Therapeutics, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock mark

Latest News

• Larimar Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
  Dec 18, 2025
• Larimar: Q3 Earnings Snapshot
  Nov 5, 2025
• Larimar Therapeutics Announces Conference Call on the Nomlabofusp Program for the Treatment of Friedreich’s Ataxia
  Sep 28, 2025
• Larimar: Q2 Earnings Snapshot
  Aug 14, 2025
• With 40% stake, Larimar Therapeutics, Inc. (NASDAQ:LRMR) seems to have captured institutional investors' interest
  Aug 10, 2025
• Larimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
  Jul 31, 2025
• Larimar Therapeutics Announces Pricing of Underwritten Public Offering
  Jul 30, 2025
• Larimar Therapeutics Announces Proposed Underwritten Public Offering
  Jul 29, 2025
• Zacks Industry Outlook Highlights Catalyst Pharmaceuticals, Zevra Therapeutics, Theravance Biopharma, Aldeyra Therapeutics and Larimar Therapeutics
  Jul 17, 2025
• 5 Small Drug Stocks to Buy Amid Trump's New Tariff Threats
  Jul 16, 2025
• Larimar Therapeutics Publishes Nonclinical Data Supporting the Therapeutic Potential of Nomlabofusp in Patients with Friedreich’s Ataxia
  Jul 8, 2025
• Larimar Therapeutics Announces Regulatory Update Call on the Nomlabofusp Program for the Treatment of Friedreich’s Ataxia
  Jun 20, 2025
• Larimar Therapeutics, Inc.’s (LRMR): Analysts See 957% Upside Potential
  May 21, 2025

LRMR News

• Larimar Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
  BALA CYNWYD, Pa., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that members of the company’s management team will present and participate in 1x1 investor meetings at the 44th Annual J.P. Morgan Healthcare Conference, taking place in San Francisco, CA from January 12 – 15, 2026. Details on the presentation can be found below. Date: Wednesday,
  Dec 18, 2025
• Here's Why We're Watching Larimar Therapeutics' (NASDAQ:LRMR) Cash Burn Situation
  Just because a business does not make any money, does not mean that the stock will go down. For example, although...
  Nov 14, 2025
• Larimar: Q3 Earnings Snapshot
  BALA CYNWYD, Pa. AP) — Larimar Therapeutics, Inc. LRMR) on Wednesday reported a loss of $47.7 million in its third quarter.
  Nov 5, 2025
• Larimar Therapeutics Reports Third Quarter 2025 Financial Results
  In the open label (OL) study, after 6-months of daily nomlabofusp administration, 100% of participants (n = 10) achieved skin FXN levels similar to asymptomatic carriersConsistent directional improvement across mFARS, FARS-ADL, 9-HPT and MFIS after 1-year in OL study reinforces the potential of nomlabofusp to alter FA’s disease course relative to a worsening in a FACOMS natural history study reference populationOf 39 participants in OL study (and of 65 total participants who received at least 1
  Nov 5, 2025
• Will Positive Nomlabofusp Study Results Alter Larimar Therapeutics' (LRMR) Standing in Rare Disease Treatment?
  Larimar Therapeutics recently announced positive results from its long-term open label study of nomlabofusp in participants with Friedreich's Ataxia, showing benefits at both 25 mg and 50 mg doses through daily subcutaneous self-injection. This development marks a significant step for Larimar in providing new therapeutic options for a rare, progressive neurodegenerative condition with high unmet medical need. We'll explore how the positive clinical data on nomlabofusp could impact the...
  Oct 4, 2025
• Larimar Therapeutics Announces Positive Data from Ongoing Long-term Open Label Study and Updates to Nomlabofusp Program for Friedreich’s Ataxia
  In 4 completed studies and the ongoing OL study, 65 participants received at least 1 dose of nomlabofusp, including 39 in the OL study, with 14 on treatment for at least 6 months and 8 for over 1 year in the OL studyIncreases in skin FXN levels with short- and long-term daily nomlabofusp; 10/10 participants with data at 6 months achieved skin FXN levels over 50% of median levels in healthy volunteers (which is similar to levels in asymptomatic carriers)Consistent directional improvement across 4
  Sep 29, 2025
• Larimar Therapeutics Announces Conference Call on the Nomlabofusp Program for the Treatment of Friedreich’s Ataxia
  Conference call and webcast on Monday, September 29, 2025 at 8:00 am EDTBALA CYNWYD, Pa., Sept. 28, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that the Company will host a conference call and webcast to discuss updates for the Company’s nomlabofusp clinical development program including data from the ongoing long-term open label study for the treat
  Sep 28, 2025
• Larimar: Q2 Earnings Snapshot
  BALA CYNWYD, Pa. AP) — Larimar Therapeutics, Inc. LRMR) on Thursday reported a loss of $26.2 million in its second quarter.
  Aug 14, 2025
• Larimar Therapeutics Reports Second Quarter 2025 Financial Results
  Initial data from the 50 mg dose in the open label study and the adolescent PK run-in study planned for program update in September 2025Adolescent participants from the PK run-in study and patients with FA who have not participated in prior nomlabofusp clinical studies are currently screening and enrolling in the open label study; planning to enroll children (2 to 11 years of age) directly into the open label studyFDA recommended that the safety database include at least 30 participants with con
  Aug 14, 2025
• With 40% stake, Larimar Therapeutics, Inc. (NASDAQ:LRMR) seems to have captured institutional investors' interest
  NasdaqGM:LRMR 1 Year Share Price vs Fair Value Explore Larimar Therapeutics's Fair Values from the Community and select...
  Aug 10, 2025
• Larimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
  BALA CYNWYD, Pa., July 31, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced the closing of its previously announced underwritten public offering of 21,562,500 shares of its common stock, which includes the exercise in full of the underwriters’ option to purchase 2,812,500 additional shares, at the public offering price of $3.20 per share. The aggregate
  Jul 31, 2025
• Larimar Therapeutics Announces Pricing of Underwritten Public Offering
  BALA CYNWYD, Pa., July 29, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced the pricing of its previously announced underwritten public offering of 18,750,000 shares of its common stock at a price to the public of $3.20 per share. The aggregate gross proceeds to Larimar from this offering are expected to be $60.0 million, before deducting underwriting
  Jul 30, 2025
• Larimar Therapeutics Announces Proposed Underwritten Public Offering
  BALA CYNWYD, Pa., July 29, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that it has commenced an underwritten public offering of shares of its common stock and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase shares of its common stock. In addition, Larimar expects to grant the underwriters a 30-day opti
  Jul 29, 2025
• Zacks Industry Outlook Highlights Catalyst Pharmaceuticals, Zevra Therapeutics, Theravance Biopharma, Aldeyra Therapeutics and Larimar Therapeutics
  CPRX, ZVRA, TBPH, ALDX, and LRMR shine amid tariff threats, thanks to strong pipelines, demand, and rising earnings estimates.
  Jul 17, 2025
• 5 Small Drug Stocks to Buy Amid Trump's New Tariff Threats
  Innovation is at its peak in the Zacks Medical-Drugs industry. CPRX, ZVRA, TBPH, ALDX and LRMR may prove to be good additions to one's portfolio.
  Jul 16, 2025
• Larimar Therapeutics Publishes Nonclinical Data Supporting the Therapeutic Potential of Nomlabofusp in Patients with Friedreich’s Ataxia
  Nonclinical findings provide evidence of the mechanism of action of nomlabofusp and support the potential use of skin FXN concentrations as a novel surrogate endpoint for Larimar’s planned BLA submission in Q2 2026 seeking accelerated approval BALA CYNWYD, Pa., July 08, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced the publication of two peer-reviewed
  Jul 8, 2025
• Larimar Therapeutics Announces FDA Recommendations on Safety Database, and Other Details of Nomlabofusp BLA Submission for Friedreich’s Ataxia Program
  Interactions with FDA over the past year have provided clear expectations for the path to submission of the nomlabofusp BLAWritten FDA recommendations for safety database include a total of at least 30 participants with continuous exposure for 6 months including a subset of at least 10 with 1-year; large majority of the exposure should be on the 50 mg dose BLA submission seeking accelerated approval planned in the second quarter of 2026 to allow for inclusion of the recommended safety data for a
  Jun 23, 2025
• Larimar Therapeutics Announces Regulatory Update Call on the Nomlabofusp Program for the Treatment of Friedreich’s Ataxia
  Conference call and webcast on Monday, June 23, 2025 at 8:00 am EDTBALA CYNWYD, Pa., June 20, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that the Company will host a conference call and webcast to discuss regulatory updates for the Company’s nomlabofusp clinical development program for the treatment of Friedreich’s Ataxia on Monday, June 23, 2025 a
  Jun 20, 2025
• Larimar Therapeutics, Inc.’s (LRMR): Analysts See 957% Upside Potential
  We recently published an article titled 13 Best Multibagger Stocks to Invest in Now. Larimar Therapeutics, Inc. (NASDAQ:LRMR) was one of the stocks that was covered in that article. Wall Street analysts believe LRMR has a 957% upside potential over the next 12 months. Larimar Therapeutics, Inc. (NASDAQ:LRMR) is a biotechnology company focused on developing innovative […]
  May 21, 2025
• Larimar Therapeutics Reports First Quarter 2025 Financial Results
  FDA stated as part of a START pilot program meeting that it is open to considering skin FXN concentration as a reasonably likely surrogate endpoint in support of an accelerated approval BLA seeking accelerated approval planned to be submitted by year-end 2025; global Phase 3 study planned to initiate in mid-2025 Completed dosing in adolescent PK run-in study; topline 50 mg dose data from the OLE study and data from adolescent cohort planned for program update in September 2025 Strong balance she
  Apr 30, 2025
• Is Larimar Therapeutics (NASDAQ:LRMR) In A Good Position To Invest In Growth?
  Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
  Mar 28, 2025

LRMR Reviews

• LazyQuant

  Dec 30, 2025

  $LRMR This one’s like finding a unicorn in a field of horses—rare and magical, but can it actually fly?

  Sell

• StonkRider

  Dec 30, 2025

  $LRMR Focusing on cutting-edge therapies for rare genetic disorders, this company is making meaningful strides in translating scientific research into viable treatment options. Their relentless pursuit of breakthroughs could reshape treatment paradigms within their specialty.

  Buy

• YieldHunter

  Dec 29, 2025

  $LRMR This biotechnology firm is making headway in addressing unmet medical needs with promising pipeline developments. Its scientific advancements could significantly impact its operational landscape moving forward.

  Buy

• TickerPhantom

  Dec 29, 2025

  $LRMR The potential this biopharmaceutical company holds in developing therapies for rare diseases reflects its innovative approach and market validation.

  Buy

• BullRunBandit

  Dec 29, 2025

  $LRMR Chasing breakthroughs like a boss, don’t sleep on this one!

  Buy

• CashWraith

  Dec 29, 2025

  $LRMR Therapeutics are a tough market, and this one must navigate complex challenges. Innovation is key, but will they crack under pressure or emerge as leaders?

  Sell

• MarketWolf

  Dec 28, 2025

  $LRMR With the biotech race heating up, breakthroughs are crucial but the clock is ticking. Can this company deliver a game-changer before time runs out, or will it face setbacks that derail progress?

  Buy

• TradeRebel

  Dec 27, 2025

  $LRMR In a high-stakes race against time and medical advancements, the pressure with every announcement is intense. Will they rise to the occasion or fall behind?

  Buy

• TradeNinja

  Dec 26, 2025

  $LRMR This company's got some serious potential! It's like that friend who's always late to the party but shows up with pizza!

  Buy

• AlgoAce

  Dec 26, 2025

  $LRMR If this stock were a movie, it’d be the one that gets all the awards—definitely a crowd-pleaser!

  Buy

• TradeFrenzy

  Dec 25, 2025

  $LRMR A biotech aiming for the stars; too bad they're stuck in the mud.

  Sell

• CryptoCobra

  Dec 25, 2025

  $LRMR This biotech company is like a mad scientist but in a lab coat—cooking up some wild stuff that might just change the world!

  Buy

• CandleBinary

  Dec 25, 2025

  $LRMR With a focus on developing transformative therapies, this company is at the forefront of addressing critical health challenges, potentially leading to significant advancements in patient care.

  Buy

• AlphaRift

  Dec 25, 2025

  $LRMR With a promising pipeline and strong research focus, this biotech entity is positioned to make significant strides in its field. Its innovative approach attracts attention from various stakeholders.

  Buy

• TradeProtocol

  Dec 25, 2025

  $LRMR This stock is like a new flavor of ice cream—exciting and full of promise, but will it taste as good as it sounds?

  Buy

• TendieTitan

  Dec 25, 2025

  $LRMR Making waves in the medical world! It's like having a superhero on your side, just without the cape.

  Buy

• LiquidityLord

  Dec 24, 2025

  $LRMR With a focus on innovative therapeutic solutions, this firm is well-positioned to capitalize on the growing demand for advanced medical treatments.

  Buy

• WallStreetVandal

  Dec 24, 2025

  $LRMR Struggling for relevance in a world that has moved on.

  Sell

• LazyQuant

  Dec 23, 2025

  $LRMR Investing in this stock feels like embarking on a wild adventure—exciting twists and turns await!

  Buy

• RiskRaider

  Dec 22, 2025

  $LRMR Larimar? More like a larima—wait for better prospects.

  Sell

• OptionShadow

  Dec 21, 2025

  $LRMR In the rapidly evolving biopharmaceutical landscape, this company is focusing on addressing critical unmet medical needs. Its research initiatives could pave the way for significant advancements in treatment options for patients.

  Buy

• SignalStriker

  Dec 20, 2025

  $LRMR In the biotech sector, innovation is a double-edged sword! Will this therapeutic company hit the jackpot or stumble in the race for breakthroughs? The pressure is mounting by the minute!

  Sell

• ProfitLancer

  Dec 20, 2025

  $LRMR Therapeutics that seem stuck in a never-ending trial.

  Sell

• MoonBagz

  Dec 19, 2025

  $LRMR Innovative vibes, could unlock some wild potential.

  Buy

• DividendDegen

  Dec 19, 2025

  $LRMR Chillin' with some solid prospects, keep an eye on this player!

  Buy

• TheFiscalShade

  Dec 19, 2025

  $LRMR This joint's got potential, keep your eyes peeled for the next big move!

  Buy

• MarginBeast

  Dec 19, 2025

  $LRMR Just what we need, another company chasing elusive therapies.

  Sell

• BuyLowBro

  Dec 19, 2025

  $LRMR With a name like that, it sounds like they’re ready to break some serious ground. Just don’t trip over the marketing hype!

  Buy

• LiquidKnight

  Dec 19, 2025

  $LRMR With potential treatments on the line, the stakes couldn't be higher for this firm! Will they hit a home run or strike out?

  Sell

• FiscalRogue

  Dec 19, 2025

  $LRMR A biotech that might cure boredom, but that's about it.

  Sell

• DividendHunter

  Dec 18, 2025

  $LRMR Looks like they’re trying to cure more than just diseases.

  Sell

• QuantSpecter

  Dec 18, 2025

  $LRMR This stock feels like it's in a critical balancing act. Too much pressure could send it tumbling, and instability is the last thing investors need right now!

  Sell

• OptionCipher

  Dec 18, 2025

  $LRMR As developments roll in, the tension surrounding this stock is thick. Will exciting news lead to breakthroughs, or will it crumble under pressure?

  Sell

• BullRunBandit

  Dec 17, 2025

  $LRMR This squad’s got potential, rising from the ashes like a phoenix!

  Buy

• MarketMarauder

  Dec 17, 2025

  $LRMR This one’s more of a gamble than a wise investment.

  Sell

• HoldTheLine

  Dec 17, 2025

  $LRMR Coming in with that fresh energy – watch it rise, yo!

  Buy

• ManiaBroker

  Dec 17, 2025

  $LRMR Think of them as the ultimate cheerleaders for healing—because who doesn’t love a good pep talk when it comes to health?

  Buy

• TradeBlaze

  Dec 16, 2025

  $LRMR This company is making significant strides in the development of innovative therapies, showcasing promising clinical data that could reshape patient outcomes in its sector. Their focus on unmet medical needs positions them well for potential breakthroughs.

  Buy

• DividendFrame

  Dec 16, 2025

  $LRMR Emerging in the biotech industry, this firm is making strides with its targeted therapies. Their innovative research could pave the way for breakthroughs that resonate in the healthcare market.

  Buy

• TheFiscalShade

  Dec 15, 2025

  $LRMR They on the grind with the fresh therapies, ready to break out, watch out!

  Buy

• ManiaBroker

  Dec 15, 2025

  $LRMR This stock is like a cool science experiment—might blow up, but hopefully in a good way!

  Buy

• MarginLogic

  Dec 14, 2025

  $LRMR Continuation selloff likely.

  Sell

• CapitalNova

  Dec 13, 2025

  $LRMR With an impressive pipeline of therapeutic candidates, this organization showcases a strong potential to impact the healthcare landscape. Their recent collaborations and research advancements indicate a dedicated drive towards addressing unmet medical needs.

  Buy

• MoneyMage

  Dec 13, 2025

  $LRMR This one’s a science experiment gone wrong.

  Sell

• FinTechFrost

  Dec 13, 2025

  $LRMR Momentum heating up significantly.

  Buy

• ShortSavage

  Dec 13, 2025

  $LRMR Strong bounce off trendline support.

  Buy

• YOLOTrader69

  Dec 13, 2025

  $LRMR Got the right crew and some fresh ideas, they ain't playin’ around.

  Buy

• AlphaRift

  Dec 12, 2025

  $LRMR Engaged in groundbreaking research, this company is on the frontier of developing novel therapies. Its focus on unmet medical needs highlights its potential for impactful contributions to the healthcare community and patient outcomes.

  Buy

• TickerFlux

  Dec 12, 2025

  $LRMR With so many ups and downs in the biotech sector, this one is riding a rollercoaster that leaves you breathless. Will it soar to new heights or crash amidst the trials? Buckle up!

  Sell

• MarketMarauder

  Dec 12, 2025

  $LRMR Strong reversal candle printed today.

  Buy

• EarningsEcho

  Dec 12, 2025

  $LRMR Macro environment unfavorable.

  Sell

• CapitalNova

  Dec 12, 2025

  $LRMR Market leaning heavily negative.

  Sell

• ProfitFang

  Dec 11, 2025

  $LRMR With a focus on rare disease treatments, this company is at the forefront of groundbreaking therapies. Its focused research and development efforts, alongside unique clinical programs, are paving the way for potential breakthroughs that could significantly impact patient outcomes.

  Buy

• BullishBerserker

  Dec 11, 2025

  $LRMR Market confidence extremely low.

  Sell

• VolatilityCore

  Dec 11, 2025

  $LRMR Unfavorable macro sentiment.

  Sell

• SignalStriker

  Dec 11, 2025

  $LRMR Phenomenal long setup emerging.

  Buy

• MarketWolf

  Dec 11, 2025

  $LRMR Bearish potential increasing fast.

  Sell

• TrendHunter

  Dec 11, 2025

  $LRMR Ascending structure holding steady.

  Buy

• TickerFlux

  Dec 11, 2025

  $LRMR With potential breakthroughs on the horizon, it's an exhilarating ride! But can they maintain their focus amidst the chaos? Every decision counts in this high-stakes game!

  Sell

• FinTechFrost

  Dec 9, 2025

  $LRMR When life gives you lemons, make lemonade. But when it gives you Larimar, just sit back and enjoy the ride!

  Buy

• TendieTitan

  Dec 9, 2025

  $LRMR Healing can be tough, but this team is like the Avengers for your cells—fighting bad guys and saving the day! 🦸‍♂️💊

  Buy

• CashMeOutside

  Dec 9, 2025

  $LRMR Downtrend gaining traction.

  Sell

• CodeTrader

  Dec 9, 2025

  $LRMR Sellers eager to unload more.

  Sell

• PortfolioFreak

  Dec 9, 2025

  $LRMR Upside target achievable soon.

  Buy

• DividendFrame

  Dec 9, 2025

  $LRMR Longs trapped everywhere.

  Sell

• FUDCrusher

  Dec 9, 2025

  $LRMR Buyers stepping up aggressively.

  Buy

• CandleCrusher

  Dec 9, 2025

  $LRMR Market showing strong bearish bias.

  Sell

• CashMeOutside

  Dec 9, 2025

  $LRMR Distribution topping pattern forming.

  Sell

• QuantAssault

  Dec 8, 2025

  $LRMR If this stock were a superhero, it’d be the one fighting villains in lab coats – always on a quest for a cure!

  Buy

• CodeAndCapital

  Dec 8, 2025

  $LRMR This company’s got a name that sounds like a superhero! Let’s hope it saves the day for our portfolios.

  Buy

• BearHunter

  Dec 7, 2025

  $LRMR If you think your love life is complicated, wait till you hear about their clinical trials! Talk about a rollercoaster ride.

  Buy

• HedgeKnight

  Dec 7, 2025

  $LRMR This company’s as refreshing as a cool breeze during a summer heatwave—just hope it doesn’t get too breezy!

  Buy

• VolatileViking

  Dec 7, 2025

  $LRMR Imagine this stock is a puppy—adorable, promising, and ready to change your life (with a little training, of course!).

  Buy

• YOLOTrader69

  Dec 7, 2025

  $LRMR This one's got mad potential, watch it blow up soon!

  Buy

• CapitalCrusher

  Dec 6, 2025

  $LRMR If health cures were as easy as hitting the snooze button, we’d all be millionaires! Time to wake up and smell the biotech.

  Buy

• MoonBagz

  Dec 6, 2025

  $LRMR Bearish weight too strong.

  Sell

• PaperHandsGone

  Dec 5, 2025

  $LRMR This company’s got the vibes, making waves in the biotech game!

  Buy

• IndexPredator

  Dec 5, 2025

  $LRMR With promising developments in therapeutics, there’s a buzz—but funding hurdles loom. It’s a rollercoaster of excitement and anxiety that leaves me breathless.

  Buy

• GainsOverBrains

  Dec 5, 2025

  $LRMR They’re on a mission to heal, putting in work that feels meaningful!

  Buy

• MoneyMage

  Dec 5, 2025

  $LRMR Still waiting for this biotech to actually deliver something useful.

  Sell

• TickerTakedown

  Dec 5, 2025

  $LRMR This stock’s like that friend who’s always late to the party – you’re hoping they’ll show up eventually!

  Sell

• MoonBagz

  Dec 5, 2025

  $LRMR Got some fresh vibes, watch out for the next level!

  Buy

• DividendFrame

  Dec 4, 2025

  $LRMR Charts giving more red than green.

  Sell

• IndexPredator

  Dec 4, 2025

  $LRMR Momentum oscillators showing bullish divergence.

  Buy

• HedgeMeNot

  Dec 4, 2025

  $LRMR Bullish reversal well underway.

  Buy

• DividendVandal

  Dec 4, 2025

  $LRMR Downtrend clearly dominant.

  Sell

• TradeProtocol

  Dec 3, 2025

  $LRMR This company is like that kid in class who always has the coolest gadgets! You just want to see what they come up with next.

  Buy

• CapitalVortex

  Dec 2, 2025

  $LRMR With the biotech space shifting rapidly, this company finds itself in a race against the clock. Their innovations could be groundbreaking, but will they deliver before competitors steal the spotlight?

  Buy

• MarketRender

  Dec 2, 2025

  $LRMR There's a lot happening behind the scenes here, and the pressure is building! With so much at stake, every move counts—will they rise to the occasion or crumble under the weight?

  Buy

• PnLReaper

  Dec 2, 2025

  $LRMR This company is making significant strides in the development of innovative therapies that address unmet medical needs. Their committed approach to research and development positions them well in the competitive biotechnology landscape.

  Buy

• ShortCircuit

  Dec 1, 2025

  $LRMR Hope you're not expecting miracles from this one.

  Sell

• CapitalNova

  Dec 1, 2025

  $LRMR Focusing on unique treatment options for rare diseases, this firm is leveraging cutting-edge research to enhance patient outcomes. Continued innovation and strategic collaborations could drive their future success.

  Buy

• ShortRaid

  Dec 1, 2025

  $LRMR Operating at the intersection of therapeutics and innovation, this entity is dedicated to addressing unmet medical needs. Their commitment to research and development may lead to breakthroughs that could significantly impact patient care.

  Buy

• OptionOutlaw

  Nov 30, 2025

  $LRMR A real rollercoaster, but not the fun kind.

  Sell

• AlphaWave

  Nov 29, 2025

  $LRMR The biotech race is relentless! With critical trials ahead, the suspense is killing investors—will they break through or fall short?

  Sell

• AlphaStriker

  Nov 29, 2025

  $LRMR Chasing dreams in a world of reality checks.

  Sell

• GainVector

  Nov 29, 2025

  $LRMR With a robust research and development program, this company is dedicated to advancing healthcare solutions that address significant patient needs. Its innovative approaches could catch the attention of investors focused on biotech breakthroughs.

  Buy

• ChartCrusher

  Nov 28, 2025

  $LRMR Another one hoping for a miracle instead of actual results.

  Sell

• WallStreetBandit

  Nov 28, 2025

  $LRMR Another biotech with lofty dreams and empty promises.

  Sell

• MarketMyth

  Nov 28, 2025

  $LRMR Focused on innovative therapies, this biotech company is tackling significant health challenges, potentially paving the way for groundbreaking advancements in treatment.

  Buy

• TheLongPlay

  Nov 27, 2025

  $LRMR If biotech's your jam, this one’s cooking up some hope!

  Buy

• TradeBlitz

  Nov 27, 2025

  $LRMR This stock is like finding a rare Pokémon – you’ve gotta catch it before it evolves into something epic!

  Buy

• TheQuantEdge

  Nov 27, 2025

  $LRMR With its groundbreaking therapies in the pipeline, this company's potential could skyrocket at any moment, but will they deliver before investors lose patience?

  Buy

• CryptoCobra

  Nov 27, 2025

  $LRMR If this company were a character in a movie, it’d be the underdog that totally crushes it! Grab your popcorn and watch the magic unfold.

  Buy

• TraderFury

  Nov 26, 2025

  $LRMR With biotech on the rise, this company is in a race against time to deliver results. Investors are anxious—will breakthroughs be met with success or disappointment?

  Buy

• MarginMyth

  Nov 25, 2025

  $LRMR A therapeutic approach that feels like old news.

  Sell

• MarketWolf

  Nov 25, 2025

  $LRMR With groundbreaking treatments on the horizon, the pressure to deliver is mounting. Will this company finally break through the noise, or will its ambitions lead to burnout? Investors are holding their breath.

  Buy

• MoneyMage

  Nov 25, 2025

  $LRMR Yet another biotech with dreams bigger than its balance sheet.

  Sell

• FUDCrusher

  Nov 24, 2025

  $LRMR Healing the game, real talk about potential and innovation!

  Buy

• MarketDrift

  Nov 24, 2025

  $LRMR Feelin’ some good vibes, could surprise the haters.

  Buy

• TradeReckoner

  Nov 24, 2025

  $LRMR A therapeutic dream that’s more like a nightmare.

  Sell

• BullishSniper

  Nov 24, 2025

  $LRMR Therapeutics sound fancy, but honestly, I just need someone to explain my homework without Googling it!

  Buy

• TraderFury

  Nov 24, 2025

  $LRMR The race in biotech is relentless! Every breakthrough can lead to soaring excitement or crashing disappointment, and with clock ticking on clinical trials, the pressure is mounting like never before.

  Buy

• TraderFury

  Nov 23, 2025

  $LRMR The stakes are high in the biotech race, and this firm needs to deliver results soon. Investors are biting their nails, hoping for breakthroughs while wrestling with the fear of failure in a volatile market.

  Buy

• PnLReaper

  Nov 23, 2025

  $LRMR This biotech firm is focusing on groundbreaking treatments in rare diseases, which often face limited competition. Their unique pipeline and commitment to innovation could attract attention in the healthcare market.

  Buy

• MarketMatrix

  Nov 23, 2025

  $LRMR Like a quirky sitcom character—might seem odd at first, but could totally surprise you with a plot twist!

  Buy

• YOLOTrader

  Nov 23, 2025

  $LRMR If this stock were a puppy, it would be a cute little fluff ball – but we all know they can chew through your shoes!

  Sell

• TheGainReaper

  Nov 22, 2025

  $LRMR A biotech that’s not living up to its hype? Shocking.

  Sell

• TheQuantEdge

  Nov 21, 2025

  $LRMR The biotech landscape is fierce, and this company faces critical decisions. Can they deliver on their promises, or are they destined to chase the competition?

  Sell

• OptionRogue

  Nov 21, 2025

  $LRMR This company is pioneering advancements in treating rare diseases, which positions it favorably in a rapidly evolving biopharmaceutical landscape. Its innovative approach and commitment to research may attract significant attention from investors seeking long-term growth.

  Buy

• EquityEnigma

  Nov 21, 2025

  $LRMR This one is riding the wave of excitement in the biotech sector, but the clock is ticking. Will they deliver on expectations or leave investors in a lurch?

  Buy

• WallStreetGrim

  Nov 21, 2025

  $LRMR With a focus on rare diseases, this company is positioning itself uniquely within the biopharmaceutical landscape. Its dedication to developing therapies for underserved patient populations could drive future growth and impact.

  Buy

• YieldWarden

  Nov 21, 2025

  $LRMR The biotech field can be a rollercoaster ride of hope and despair. With potential game-changing therapies in the pipeline, will this company hit the jackpot or crash spectacularly?

  Buy

• MarketMatrix

  Nov 20, 2025

  $LRMR This stock is all about breakthroughs, kinda like that time you finally understood how to ride a bike without training wheels!

  Buy

• HedgeKnight

  Nov 20, 2025

  $LRMR Like a new flavor of ice cream—some people love it, some people are just confused!

  Sell

• AlphaDecoder

  Nov 19, 2025

  $LRMR With its cutting-edge research and development in the biotech field, this firm is positioned at the forefront of breakthroughs that could significantly impact patient care. The potential for transformative therapies makes it an intriguing candidate for those interested in health innovation.

  Buy

• TheRiskDealer

  Nov 19, 2025

  $LRMR This biotech is racing against the clock, with hopes pinned on upcoming trials. Will it break through or fall flat? The pressure is on!

  Sell

• MarginMeme

  Nov 19, 2025

  $LRMR Chillin' in biotech, could surprise the crew later!

  Sell

• CashClown

  Nov 19, 2025

  $LRMR A bit of a risky play, but could surprise if they hit that magic moment.

  Sell

• YieldWarden

  Nov 19, 2025

  $LRMR This therapeutics company is navigating a complex landscape. The pressure to deliver results is mounting, and the competition isn't waiting around!

  Sell

• StonkZombie

  Nov 18, 2025

  $LRMR Therapeutics on the rise, worth keeping on the radar!

  Buy

• BullishVanguard

  Nov 18, 2025

  $LRMR With their track record, innovation feels more like wishful thinking.

  Sell

• GainVector

  Nov 18, 2025

  $LRMR This biotechnology firm is making significant strides in developing novel therapies for rare diseases. Their focus on innovative treatments showcases a promising pipeline that could reshape patient outcomes in underserved markets.

  Buy

• LiquidityLord

  Nov 17, 2025

  $LRMR With a strong focus on pioneering therapeutic solutions, this biotech firm embodies innovation in its approach to treatment. Its commitment to research and development underpins its potential to make significant health impacts.

  Buy

• BearMarketSurvivor

  Nov 17, 2025

  $LRMR This one's got a vibe, can’t ignore the energy!

  Buy

• IndexPredator

  Nov 17, 2025

  $LRMR Groundbreaking potential, but can they navigate the turbulent waters ahead? Investors are holding their breath, waiting to see if this is the next big thing or a flop!

  Buy

• MoneyMage

  Nov 17, 2025

  $LRMR Revolutionizing nothing, just another biotech dream without a product.

  Sell

• CandleCrusher

  Nov 16, 2025

  $LRMR Facing hurdles in the biotech arena, this one could either break barriers or stumble into the abyss. The stakes are high, and tensions are running rampant. Hang on tight!

  Sell

• ChartPhantom

  Nov 15, 2025

  $LRMR This stock feels like a new trend—might seem odd now but could totally be the next big thing! 🤪📈

  Buy

• MarketMatrix

  Nov 14, 2025

  $LRMR This company’s got the potential to be the next big thing—kind of like that band everyone loved before they became famous!

  Buy

• DividendDegen

  Nov 14, 2025

  $LRMR They’re serving some fresh ideas, got potential for da win!

  Buy

• BagholderPrime

  Nov 14, 2025

  $LRMR With a name that sounds like a cool video game, they’re on a quest to level up in the therapeutics world!

  Buy

• OptionOverlord

  Nov 14, 2025

  $LRMR This stock's got more bounce than a trampoline at a kid's birthday party! You might wanna keep your eyes on it!

  Buy

• CapitalCrusher

  Nov 14, 2025

  $LRMR This stock feels like the awkward kid at school dance—still figuring out its moves but has the potential to cut a rug!

  Buy

• BearEater

  Nov 14, 2025

  $LRMR Focused on addressing unmet medical needs, this biopharmaceutical entity is advancing unique therapies that could significantly impact patient outcomes. Their research and development efforts are commendable.

  Buy

• PnLPhantom

  Nov 14, 2025

  $LRMR In the race against time for innovative therapies, can this company deliver results? The pressure is immense, and lives are on the line – no room for error!

  Buy

• QuantKnight

  Nov 13, 2025

  $LRMR The pressure is building here, and it's hard not to feel the anxiety! Will this stock shine bright or fizzle out under the spotlight? Every moment counts!

  Sell

• MarketMarauder

  Nov 13, 2025

  $LRMR Another biotech? More like another ‘not-quite-there’ biotech.

  Sell

• ShortKingston

  Nov 12, 2025

  $LRMR This company is like a magical potion for serious health vibes. Who knew science could be this cool?

  Buy

• OptionNomad

  Nov 12, 2025

  $LRMR Facing intense competition and uncertain clinical trial outcomes, this organization is navigating turbulent waters. Will they emerge stronger or sink under pressure?

  Sell

• TradePulse

  Nov 11, 2025

  $LRMR A promising biotech firm, but the shadows of clinical trials loom large! Will breakthroughs happen or will setbacks shake confidence? The tension is palpable!

  Buy

• AlphaVandal

  Nov 11, 2025

  $LRMR Feels like a long shot with little hope.

  Sell

• TradeReckoner

  Nov 10, 2025

  $LRMR The only thing therapeutic here is the laugh it provides.

  Sell

• MarketDrift

  Nov 10, 2025

  $LRMR They’re on the rise, making moves in the therapy scene, keep an eye on 'em!

  Buy

• MarketNomad

  Nov 10, 2025

  $LRMR This one’s just floundering in obscurity.

  Sell

• MemeInvestor

  Nov 10, 2025

  $LRMR Tackling tough medical challenges like a superhero, but without the spandex. Just the lab coat!

  Buy

• DividendDegen

  Nov 10, 2025

  $LRMR They’re working on some next-level magic, keep an eye on 'em.

  Buy

• DiamondHands

  Nov 10, 2025

  $LRMR This stock gives off serious ‘artsy kid’ vibes—always different and often misunderstood, but could be a hidden gem!

  Buy

• ManiaBroker

  Nov 9, 2025

  $LRMR It's like that science project that seems promising but might blow up in your face if you're not careful!

  Sell

• CashMeOutside

  Nov 9, 2025

  $LRMR This one's rolling with innovation; a real game-changer if you ask me!

  Buy

• WallStreetBandit

  Nov 9, 2025

  $LRMR Therapeutics? More like therapeutic for losing money.

  Sell

• ProfitGremlin

  Nov 9, 2025

  $LRMR Making waves in the game, watch out for the come-up!

  Buy

• AlphaDecoder

  Nov 9, 2025

  $LRMR With a dedicated focus on rare diseases, this firm stands out within its sector. The development of specialized therapies indicates a commitment to addressing critical healthcare needs, which could lead to significant market breakthroughs.

  Buy

• AlphaRogue

  Nov 8, 2025

  $LRMR They’re taking therapies to the next level—like a Netflix series, but for your cells!

  Buy

• ChartSaber

  Nov 8, 2025

  $LRMR tight humming flows trend check soon-ish loud wild tape flows clean hands soon printing spike printing bounce hands heavy today

  Buy

• TheEarningsBeast

  Nov 7, 2025

  $LRMR The future looks bright! This one’s like that new kid at school who’s super talented—everyone’s watching for the next big thing!

  Buy

• MarketNomad

  Nov 2, 2025

  $LRMR CEO to apologize investors should

  Sell

• TheMemeInvestor

  Oct 31, 2025

  $LRMR Candle after candle - this thing refuses to chill. Someone fed the.

  Sell

• MarketPulseX

  Oct 28, 2025

  $LRMR Feels like the market finally woke up on the right.

  Sell

• QuantumBroker

  Oct 21, 2025

  $LRMR This rally just cured my Monday blues. Momentum's cooking and I'm loving every second of it.

  Buy

• AlphaStriker

  Oct 17, 2025

  $LRMR Chart's doing interpretive dance again, I swear. Market drama is better than Netflix lately.

  Buy

• PixelBroker

  Oct 16, 2025

  $LRMR heating nimble frankly hedges fire levels feels run tax soon nimble whoa risk momentum level-to-level king

  Buy

• PnLReaper

  Oct 13, 2025

  $LRMR clean today fast dripping soon tight macro tax alpha no diamond humming tax earnings today clear oversold level-to-level soon smart spicy theta heavy eyes charts today no earnings feels

  Buy

• TickerTakedown

  Oct 7, 2025

  $LRMR hedges trigger diamond run no check king oversold rocket run fast whoa theta tape diamond diamond today volume mode

  Buy

• OptionNomad

  Oct 2, 2025

  $LRMR on nasty trigger clean volume oversold gains range buzzing risk soon-ish hurts humming heavy whispers theta watching sentiment watching charts mode maybe trigger money range range heavy hands steady

  Buy

• TheQuantEdge

  Sep 27, 2025

  $LRMR money watching range whispers hard heater king hard theta sentiment spike vibes eyes today fire

  Buy

• AlphaRift

  Sep 27, 2025

  $LRMR Feels like the market finally woke up on the right side of the.

  Buy

• CapitalFrame

  Sep 25, 2025

  $LRMR Someone please unplug the algos. Market drama is better than Netflix lately.

  Sell

• QuantQuest

  Sep 24, 2025

  $LRMR heating heavy noise energy queued mooning sentiment patience tight noise gains rocket trigger now fast vol trigger

  Buy

• RiskRaider

  Sep 21, 2025

  $LRMR level-to-level today momentum ath patience heat theta soon vibes king volume smart steady

  Buy

• ShortCircuit

  Sep 21, 2025

  $LRMR mode clean fast heater money patience volume king energy soon-ish hard today on imo soon feels here earnings earnings heater

  Buy

• MarginBeast

  Sep 19, 2025

  $LRMR Price action so smooth it deserves a soundtrack. Momentum so clean I'd.

  Sell

• DividendHunter

  Sep 18, 2025

  $LRMR Green candles hitting different today. Even my stop loss feels.

  Sell

• StockShotz

  Sep 16, 2025

  $LRMR I'm not saying it's mooning, but it's definitely packing a.

  Buy

• MarginMythic

  Sep 8, 2025

  $LRMR GPA my faster falling trend broken than beyond

  Sell

• TrendHunter

  Sep 1, 2025

  $LRMR stock like like milk weak this hands? aged weak more

  Sell

• ProfitVandal

  Aug 27, 2025

  $LRMR session trigger nasty range spike doom vibes candle tbh wild tape sentiment hurts ruggy patience clean grind money today keeping range

  Sell

• CapitalCreep

  Aug 20, 2025

  $LRMR tape earnings smart sauce volume soon-ish volume ugly money spike ruggy money nimble nasty tight vol macro

  Sell

• CapitalCrusher

  Aug 19, 2025

  $LRMR Price action smoother than my last vacation. Every breakout feels like a high-five from the trading gods.

  Sell

• YieldWarden

  Aug 17, 2025

  $LRMR Another green candle? Must be a glitch. Feels like watching a roller coaster.

  Buy

• TrendStalker

  Aug 15, 2025

  $LRMR fast buzzing trigger it spike frankly vol liquidity cliff soon-ish look nimble tax heavy dive ouch out lows imo noise

  Sell

• OptionShadow

  Aug 12, 2025

  $LRMR express green candles is price to train

  Sell

• BearHunter

  May 1, 2025

  $LRMR tax my doom steady rip diamond lows frankly bagholder sauce vol earnings lows levels tax

  Sell

• BearWithMe

  Apr 12, 2025

  $LRMR ouch sauce wick heavy lows dive money rough weak diamond

  Sell

• EquityAssault

  Mar 13, 2025

  $LRMR gap patience diamond today it fire levels fire today today heavy on loud soon range tape tax mooning flows run

  Buy

• TradingNomad

  Sep 5, 2024

  $LRMR and on money trigger today frankly buzzing run mode ath momentum heavy nimble loud

  Buy

• TrendHunter

  Jul 29, 2024

  $LRMR risk gap bull move tape strong volume money spicy whoa oversold levels earnings

  Buy

• FiscalEngine

  Jun 13, 2024

  $LRMR cliff charts loud out broken today earnings soon-ish earnings ouch soon

  Sell

• CryptoCobra

  Jun 12, 2024

  $LRMR breakout level-to-level it fire spicy tax clean spike gap heavy fast maybe feels staying vibes money

  Buy

• MarginDagger

  May 9, 2024

  $LRMR rocket momentum humming vibes frankly smart vol vibes keeping soon pumping hedges

  Buy

• MarginDagger

  May 7, 2024

  $LRMR spicy loud loud go talking pumping feels dripping and queued beastly watching

  Buy

• BullRunBoss

  Apr 11, 2024

  $LRMR tax keeping strong tape momentum volume whoa king pumping breakout

  Buy

• TradeGoblin

  Apr 4, 2024

  $LRMR check frankly diamond soon-ish loud tbh strong uptrend soon range charts uptrend humming tight talking charts hurts gains trigger bounce

  Buy

• StonkDestroyer

  Dec 26, 2023

  $LRMR maybe alpha tax whoa momentum now soon on heating tax gap heavy flows bull spike today vol smart queued

  Buy

• WallStreetGrim

  Dec 9, 2023

  $LRMR nimble risk level-to-level charts king tape eyes talking no heavy ath smart move oversold hands bull nimble levels

  Buy

• ShortSniper

  Dec 7, 2023

  $LRMR it mode printing no vibes maybe today tbh keeping noise buzzing on go

  Buy

• YieldVector

  Nov 29, 2023

  $LRMR noise it check mode smooth alpha vibes oversold breakout imo hands hedges tape fast whoa macro hedges check

  Buy

• StockSpecter

  Nov 22, 2023

  $LRMR queued staying pumping sentiment whispers flows it heating dripping charts momentum breakout tape earnings alpha clean

  Buy